Bausch & Lomb bags eyeonics

Article

Bausch & Lomb has acquired eyeonics, the maker of the crystalens accommodating IOL.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Related Content
A baby is hugged by their parent in a doctor's office during an exam. Concept image for retinoblastoma diagnosis and treatment, importance of early intervention in paediatric ocular disease. Image credit: ©phoderstock – stock.adobe.com

Patient outcomes in retinoblastoma impacted by parents' interventional delays

Lynda Charters
August 16th 2025
Article
Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
August 16th 2025
Podcast
A glass building with a sign reading "RESERVE BANK." There are $100 Australian bank notes superimposed over the image. Concept image for Mirugen funding, cell reprogramming biologic biotech business of retina care news. Image credit: ©Rose Makin – stock.adobe.com

Australian biotech firm Mirugen secures major funding for cell reprogramming therapy

Hattie Hayes
August 16th 2025
Article
An hourglass with a brain in the top. The brain is falling through the hourglass like sand. The brain is crumbling into small pieces. The brain falls through the hourglass. Concept image for neurodegeneration, neurodegenerative disease, mitochondrial disease and biomarkers. Image created with Canva AI.

Eyeing the brain: How ocular mitochondrial disease may predict dementia risk

Viha Vig
August 16th 2025
Article
A map of Europe, and a circular frame patterned with the European Union flag, superimposed over binary code, numbers and charts. Concept image for commercialisation licensing business agreement of European pharmaceutical, EMEA ranibizumab biosimilar. Image credit: ©vectorfusionart – stock.adobe.com

Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions

Martin David Harp
August 16th 2025
Article
A young woman is assessed by her doctor. Concept image for tubulointerstitial nephritis and uveitis TINU case study. Image credit: ©Monkey Business – stock.adobe.com

German case study illustrates systemic presentation of tubulointerstitial nephritis and uveitis

August 16th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.